l-Proline protects mice challenged by Klebsiella pneumoniae bacteremia
Objective: K. pneumoniae, a common pathogen that frequently causes bacteremia in clinic, is unresponsive to most of known antibiotics, thus cumulatively exacerbating empirical therapy failures. Effective strategies to control Klebsiella pneumoniae bacteremia are in high demand. One possibility is to...
Main Authors: | Xuedong Chen, Sihua Qin, Xin Zhao, Shaosong Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118219300799 |
Similar Items
-
Risk factors for KPC-producing Klebsiella pneumoniae bacteremia
by: Felipe F. Tuon, et al. -
Evaluation of Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae Bacteremia
by: Pınar Kıran, et al.
Published: (2020-03-01) -
Klebsiella pneumoniae Bacteremia and Capsular Serotypes, Taiwan
by: Chun-Hsing Liao, et al.
Published: (2011-06-01) -
Klebsiella ESBL bacteremia-mortality and risk factors
by: Felipe Francisco Tuon, et al. -
Successful treatment of hypervirulent Klebsiella pneumoniae bacteremia with combination carbapenem and rifampicin
by: Yong-Chun Lin, et al.
Published: (2021-01-01)